InsidersTradesSigma
Browse the full insider trade history of PHARMANUTRA PHARMANUTRA - PHN: IL CDA APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2025, a publicly traded company based in Italy. Shares are quoted on IT IT, under the authority of Consob. Every trade is free.
0 of 0 declarations